Diagnostic Test News Today

also tonight... president zelensky takes his appeal for more weapons — and fighterjets for ukraine — to brussels. and... # ijust dont know what to do with myself. well remember burt bacharach — the man behind dozens of hit songs — who has died. and on bbc london, donations from londoners for earthquake and coming up on the bbc news channel, the idea has been dismissed once already but there are fresh calls for a european super league. welcome to the programme, on a day when the...

suspicion of attempted murder is now walking free. im john roberts. welcome to "america reports" and welcome back to you today. >> gillian: thank you so much. good to see you. >> aishah: im aishah hasnie. sandra has the day off. the man approached a man from behind and threw a punch to his head. >> john: the victim slammed his head on the concrete. doctors say he has a fractured skull, broken cheekbone and a brain bleed. >> aishah: wow, despite the attackers extensive criminal history,...

SALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven

Molecular Residual Disease study and multiple RiskScore studies among seven new datasets to be shared by Myriad and Collaborators SALT LAKE CITY, May 23, 2024 -- Myriad Genetics, Inc., , a leader...

Soldiers can suffer brain injury if they are repeatedly exposed to explosive blasts, a new study shows.

NHS spending on scans by the private sector has tripled - while the number carried out has fallen, official figures show.

Antrum Biotech has integrated serological pipette controllers from INTEGRA Biosciences into its laboratories

The first-ever DNA test to help determine if someone has a greater risk of developing opioid use disorder was approved by the Food and Drug Administration (FDA) this week. The FDA approved the AutoGenomics AvertD test for use among adults who are considering treating acute pain with short-term prescription of opioid pain medicine, such as after…

A new study finds that sepsis is often misdiagnosed, and physicians assessments for the same case vary widely.

Cytovale, a San Francisco-based medical diagnostics company, raised $84 million in Series C funds to advance the commercialization of its diagnostic test for early sepsis detection. Using standard blood draws, the test provides results in under 10 minutes. It is meant to detect sepsis in patients who present to hospital emergency departments.